Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.

Jasmin GalperManisha BalwaniStanley FahnCheryl WatersLynne KrohnZiv Gan-OrNicolas Dzamko Roy N Alcalay

Published in: Movement disorders : official journal of the Movement Disorder Society (2021)

GD plasma biomarkers are not promising candidates for stratifying the risk for PD in carriers of heterozygous GBA pathogenic variants. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Keyphrases

parkinson disease
deep brain stimulation
early onset
copy number
replacement therapy
randomized controlled trial
systematic review
gene expression
dna methylation